Inovio Pharma
(INO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 178,700 | 215,433 | 158,447 | 22,196 | 15,853 |
| Marketable Securities | 158,536 | 156,231 | 111,551 | 67,338 | 77,946 |
| Receivables | 8,194 | 3,996 | 1,276 | 2,032 | 1,755 |
| TOTAL | $377,065 | $382,062 | $275,544 | $94,201 | $98,813 |
| Non-Current Assets | |||||
| PPE Net | 11,191 | 11,324 | 12,104 | 12,773 | 13,516 |
| Investments And Advances | 5,112 | 20,045 | 21,211 | 6,315 | 7,997 |
| Intangibles | 13,797 | 13,934 | 14,071 | 14,207 | 14,474 |
| Other Non-Current Assets | 30,650 | 15,821 | 15,992 | 16,455 | 16,734 |
| TOTAL | $60,749 | $61,123 | $63,377 | $49,751 | $52,721 |
| Total Assets | $437,814 | $443,185 | $338,921 | $143,952 | $151,533 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 24,328 | 17,729 | 11,283 | 18,967 | 10,247 |
| Accrued Expenses | 5,841 | 6,871 | 5,061 | 4,050 | 4,501 |
| TOTAL | $41,263 | $37,982 | $32,295 | $31,989 | $19,547 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,152 | 13,719 | 12,825 | 12,843 | 7,955 |
| Deferred Revenues | 8,830 | 11,182 | 13,818 | 6,898 | 2,788 |
| Other Non-Current Liabilities | 68,247 | 205,438 | 106,274 | 93,932 | 88,073 |
| TOTAL | $72,551 | $218,843 | $118,772 | $106,557 | $95,868 |
| Total Liabilities | $113,814 | $256,825 | $151,067 | $138,547 | $115,415 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 14,112 | 13,954 | 13,169 | 12,145 | 8,331 |
| Common Shares | 168 | 159 | 146 | 101 | 99 |
| Retained earnings | -881,859 | -901,030 | -772,327 | -739,786 | -702,124 |
| Other shareholders' equity | -152 | -514 | 2,072 | 2,442 | 3,126 |
| TOTAL | $324,000 | $186,361 | $187,854 | $5,405 | $36,119 |
| Total Liabilities And Equity | $437,814 | $443,185 | $338,921 | $143,952 | $151,533 |